1-4 of 4
immunoconjugates
Close
Sort by
Journal Articles

Intermediate-risk acute myeloid leukemia therapy: current and future

Konstanze Döhner, Peter Paschka
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 34–43.
https://doi.org/10.1182/asheducation.V2014.1.34.3882398
Published: 2014
Journal Articles

New immune strategies for the treatment of acute lymphoblastic leukemia: antibodies and chimeric antigen receptors

Anjali S. Advani
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 131–137.
https://doi.org/10.1182/asheducation-2013.1.131
Published: 2013
Journal Articles

The prevalent predicament of relapsed acute myeloid leukemia

Jeffrey Szer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 43–48.
https://doi.org/10.1182/asheducation.V2012.1.43.3798183
Published: 2012
Journal Articles

New Strategies for the Treatment of Acute Myeloid Leukemia Including Antibodies and Other Novel Agents

Martin S. Tallman
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 143–150.
https://doi.org/10.1182/asheducation-2005.1.143
Published: 2005